Perbedaan Cipta Sarana Medika Tbk. dan Phapros Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Phapros Tbk. diperdagangkan di Rp256 (kapitalisasi pasar 211,68 M, volume 24 jam 116,4 rb). Perbedaan utamanya: Phapros Tbk. lebih besar dari sisi kapitalisasi pasar, dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 116,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | PEHA | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 211,68 M |
Volume | 8,21 jt | 116,4 rb |
Lot | 82,15 rb | 1,16 rb |
Perputaran | 515,2 jt | 29,27 jt |
Harga Rata-rata | 62,72 | 251,47 |
Nilai Transaksi | 515,2 jt | 29,27 jt |
Harga Ekuilibrium Indikatif | 63 | 256 |
Volume Ekuilibrium Indikatif | 1,33 rb | 20 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Selengkapnya di halaman PEHA →